477 related articles for article (PubMed ID: 26068539)
61. A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty.
Fuji T; Fujita S; Tachibana S; Kawai Y
J Thromb Haemost; 2010 Nov; 8(11):2458-68. PubMed ID: 20723033
[TBL] [Abstract][Full Text] [Related]
62. Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†.
O'Donoghue ML; Ruff CT; Giugliano RP; Murphy SA; Grip LT; Mercuri MF; Rutman H; Shi M; Kania G; Cermak O; Braunwald E; Antman EM
Eur Heart J; 2015 Jun; 36(23):1470-7. PubMed ID: 25687352
[TBL] [Abstract][Full Text] [Related]
63. [Periprocedural edoxaban interruption is associated with low bleeding and thromboembolic risk: the Italian data of the EMIT-AF/VTE study].
Fazio G; Squizzato A; Mazzetti M; Mannarini A; Fischetti A; Colonna P
G Ital Cardiol (Rome); 2021 Jan; 22(1):70-79. PubMed ID: 33470246
[TBL] [Abstract][Full Text] [Related]
64. Oral anticoagulation with edoxaban.
Ahrens I; Bode C
Hamostaseologie; 2012; 32(3):212-215. PubMed ID: 29589362
[TBL] [Abstract][Full Text] [Related]
65. Edoxaban: a focused review of its clinical pharmacology.
Lip GY; Agnelli G
Eur Heart J; 2014 Jul; 35(28):1844-55. PubMed ID: 24810388
[TBL] [Abstract][Full Text] [Related]
66. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
Medina A; Raskob G; Ageno W; Cohen AT; Brekelmans MPA; Chen CZ; Grosso MA; Mercuri MF; Segers A; Verhamme P; Vanassche T; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
Thromb Haemost; 2017 Dec; 117(12):2406-2414. PubMed ID: 29212128
[TBL] [Abstract][Full Text] [Related]
67. Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.
Blann AD; Boriani G; Lip GY
Europace; 2016 Oct; 18(10):1507-1513. PubMed ID: 27876695
[TBL] [Abstract][Full Text] [Related]
68. Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.
Ma TK; Yan BP; Lam YY
Pharmacol Ther; 2011 Feb; 129(2):185-94. PubMed ID: 20920530
[TBL] [Abstract][Full Text] [Related]
69. Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation.
Steffel J; Ruff CT; Yin O; Braunwald E; Park JG; Murphy SA; Connolly S; Antman EM; Giugliano RP
J Am Coll Cardiol; 2021 Mar; 77(9):1197-1207. PubMed ID: 33663737
[TBL] [Abstract][Full Text] [Related]
70. Edoxaban administration following enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects.
Zahir H; Matsushima N; Halim AB; He L; Zhang G; Lee F; Worland V; Mendell J
Thromb Haemost; 2012 Jul; 108(1):166-75. PubMed ID: 22628060
[TBL] [Abstract][Full Text] [Related]
71. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.
Zelniker TA; Ruff CT; Wiviott SD; Blanc JJ; Cappato R; Nordio F; Mercuri MF; Lanz H; Antman EM; Braunwald E; Giugliano RP
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):176-185. PubMed ID: 30039978
[TBL] [Abstract][Full Text] [Related]
72. The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design.
De Caterina R; Agnelli G; Laeis P; Unverdorben M; Rauer H; Wang CC; Nakamura M; Chiu KM; Reimitz PE; Koretsune Y; Chen C; Thee U; Kaburagi J; Kim YH; Choi WI; Yamashita T; Cohen A; Kirchhof P
Clin Cardiol; 2019 Dec; 42(12):1147-1154. PubMed ID: 31650560
[TBL] [Abstract][Full Text] [Related]
73. Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats.
Morishima Y; Honda Y; Kamisato C; Tsuji N; Kita A; Edo N; Shibano T
Thromb Res; 2012 Sep; 130(3):514-9. PubMed ID: 22647432
[TBL] [Abstract][Full Text] [Related]
74. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
; Büller HR; Décousus H; Grosso MA; Mercuri M; Middeldorp S; Prins MH; Raskob GE; Schellong SM; Schwocho L; Segers A; Shi M; Verhamme P; Wells P
N Engl J Med; 2013 Oct; 369(15):1406-15. PubMed ID: 23991658
[TBL] [Abstract][Full Text] [Related]
75. Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.
De Caterina R; Ageno W; Boriani G; Colonna P; Ghirarduzzi A; Patti G; Rossini R; Rubboli A; Schinco P; Agnelli G
Adv Ther; 2017 Mar; 34(3):620-637. PubMed ID: 28194578
[TBL] [Abstract][Full Text] [Related]
76. Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty.
Mochizuki T; Ikari K; Yano K; Hiroshima R; Ishibashi M; Okazaki K
Mod Rheumatol; 2019 Jul; 29(4):682-686. PubMed ID: 30041559
[No Abstract] [Full Text] [Related]
77. [Edoxaban (LIXIANA®) : new oral anticoagulant forthetreatment and secondary prevention of thromboembolic disease].
Scheen AJ; Lancellotti P
Rev Med Liege; 2016 Nov; 71(11):517-524. PubMed ID: 28387109
[TBL] [Abstract][Full Text] [Related]
78. The current and future role of the novel oral anticoagulants--indications beyond atrial fibrillation.
Lee A; Rajaratnam R
Heart Lung Circ; 2014 Jan; 23(1):2-9. PubMed ID: 24183214
[TBL] [Abstract][Full Text] [Related]
79. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
[TBL] [Abstract][Full Text] [Related]
80. An Open-Label Crossover Study of the Pharmacokinetics of the 60-mg Edoxaban Tablet Crushed and Administered Either by a Nasogastric Tube or in Apple Puree in Healthy Adults.
Duchin K; Duggal A; Atiee GJ; Kidokoro M; Takatani T; Shipitofsky NL; He L; Zhang G; Kakkar T
Clin Pharmacokinet; 2018 Feb; 57(2):221-228. PubMed ID: 28512699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
